Antibacterial Action of Bacillus coagulans Against Diverse Pathogens and its Relevance as Probiotics

Authors

  • Monika Gujjar
  • Sakshi Tewari

DOI:

https://doi.org/10.37591/rrjomv.v13i2.3262

Keywords:

Probiotics, Sporlac, Bacillus coagulans, antibacterial, Escherichia coil, Pseudomonas, Staphylococcus

Abstract

Probiotics are living organisms that give benefits to the host organism by improving the intestinal microbial balance. Probiotics have various beneficial effects as it maintains a healthy gut, healthy vaginal flora and boost the immune system. There are different strains of lactic acid bacteria that are used as probiotics but Bacillus coagulans is a good bacterium that is used in the form of probiotic supplements. In the present study, B. coagulans was isolated from the probiotic medicine named Sporlac-DS using De Man, Rogosa and Sharpe agar medium at 37°C for 24 h. Isolated strain was monitored for its morphological, biochemical, and physiological examinations under in vitro conditions. It was monitored that the strain was gram-positive, rod-shaped bacteria, and displayed high milk curdling activity. Biochemical analysis proved that the strain was catalase-positive and fermented glucose and lactose. The antibacterial activity of the isolated strain was further confirmed when its inhibitory potential was observed against test organisms like Pseudomonas, Staphylococcus, and Escherichia coli by well diffusion assay. Clear zones of 8 mm, 10 mm, and 7 mm diameter, respectively, were observed when Pseudomonas, Staphylococcus, and E. coil were spread on the plate, respectively. The reason for this inhibition may be the diverse antagonistic mechanisms working in synchrony viz. lactic acid + bacteriocins. Hence, the study recommends the usage of Sporlac tablets due to their antimicrobial action against diverse pathogens and boost the immune system. Currently, Sporlac is taken during constipation, irritable bowel syndrome, diarrhea, gas, indigestion, and many other conditions, but there is also evidence that intake of Sporlac helps in treating bacterial vaginosis in females.

References

Emokpae MA, Brown SI. Effects of lifestyle factors on fertility: practical recommendations for modification. Reprod Fertil. 2021;2(1):R13–26. doi: 10.1530/RAF-20–0046.

Tabish SA. Lifestyle diseases: consequences, characteristics, causes and control. J Cardiol Curr Res. 2017;9(3):00326.

Zendeboodi F, Khorshidian N, Mortazavian AM, da Cruz AG. Probiotic: conceptualization from a new approach. Curr Opsin Food Sci. 2020 Apr 1;32:103–23. doi: 10.1016/j.cofs.2020.03.009.

Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582–610. doi: 10.1128/CMR.00040–09.

Czajkowski K, Broś-Konopielko M, Teliga-Czajkowska J. Urinary tract infection in women. Prz Menopauzalny. 2021;20(1):40–7. doi: 10.5114/pm.2021.105382.

Khedkar R, Pajai S. Bacterial vaginosis: A comprehensive narrative on the etiology, clinical features, and management approach. Cureus. 2022;14(11):e31314. doi: 10.7759/cureus.31314.

Shi LH, Balakrishnan K, Thiagarajah K, Mohd Ismail NI, Yin OS. Beneficial properties of probiotics. Trop Life Sci Res. 2016;27(2):73–90. doi: 10.21315/tlsr2016.27.2.6.

Konuray G, Erginkaya Z. Potential use of Bacillus coagulans in the food industry. Foods. 2018;7(6):92. doi: 10.3390/foods7060092.

Becerra SC, Roy DC, Sanchez CJ, Christy RJ, Burmeister DM. An optimized staining technique for the detection of gram positive and Gram negative bacteria within tissue. BMC Res Notes. 2016 Dec;9(1):216. doi: 10.1186/s13104–016–1902–0.

Aulitto M, Fusco S, Bartolucci S, Franzén CJ, Contursi P. Bacillus coagulans MA-13: a promising thermophilic and cellulolytic strain for the production of lactic acid from lignocellulosic hydrolysate. Biotechnol Biofuels. 2017 Dec;10:210. doi: 10.1186/s13068–017–0896–8.

Bayoub K, Baibai T, Mountassif D, Retmane A, Soukri A. Antibacterial activities of the crude ethanol extracts of medicinal plants against Listeria monocytogenes and some other pathogenic strains. Afr J Biotechnol. 2010;9(27):4251–8.

Sanzyme Biologics. (2023). Pioneer in Probiotics with Five Decades of Fermentation Expertise. [online]. Sanzymebiologics. Available from: https://www.sanzymebiologics.com/

U.S. Food and Drug Administration. (2023). GRAS Notice (GRN) No. 864. GRAS Notification for Bacillus coagulans SNZ1969 spore preparation. Available from: https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory.

Ahmad A, Yap WB, Kofli NT, Ghazali AR. Probiotic potentials of Lactobacillus plantarum isolated from fermented durian (Tempoyak), a Malaysian traditional condiment. Food Sci Nutr. 2018;6(6):1370–7. doi: 10.1002/fsn3.672.

Lee DS, Lee SJ, Choe HS. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. BioMed Res Int. 2018;2018:7656752. doi: 10.1155/2018/7656752.

Taylor TA, Unakal CG. Staphylococcus aureus Infection. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.

Cao J, Yu Z, Liu W, Zhao J, Zhang H, Zhai Qixiao, et al. Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases. J Funct Foods. 2020;64:103643. doi: 10.1016/j.jff.2019.103643.

Downloads

Published

2023-09-02

Issue

Vol. 13 No. 2 (2023)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.